- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.05. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 08.05. | Shuttle Pharma erreicht Halbzeitmarke bei Glioblastom-Studie | 3 | Investing.com Deutsch | ||
| 21.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 | 1 | GlobeNewswire (USA) | ||
| 10.04. | Shuttle Pharma reicht Patent für Krebsbehandlungsinnovation ein | 1 | Investing.com Deutsch | ||
| 10.04. | Shuttle Pharma files patent for cancer treatment innovation | 2 | Investing.com | ||
| 10.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer | 81 | GlobeNewswire (Europe) | Filing provisional patent application with the USPTO entitled "PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy" key to advancement of Diagnostic and Therapeutic programs Dr. Alan... ► Artikel lesen | |
| 25.03. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.03. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering | 1 | GlobeNewswire (USA) | ||
| 12.03. | Shuttle Pharma ernennt neuen Interims-Co-CEO | 2 | Investing.com Deutsch | ||
| 12.03. | Shuttle Pharma appoints new interim co-CEO | 1 | Investing.com | ||
| 12.03. | Shuttle Pharmaceuticals appoints Christopher Cooper as interim co-CEO | 1 | Seeking Alpha | ||
| 12.03. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities | 135 | GlobeNewswire (Europe) | GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
| 12.03. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.03. | Shuttle Pharmaceuticals Holdings, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 27.02. | Shuttle Pharmaceuticals reports FY results | 1 | Seeking Alpha | ||
| 26.02. | Shuttle Pharma macht Fortschritte bei Glioblastom-Studie und erweitert Diagnostik | - | Investing.com Deutsch | ||
| 26.02. | Shuttle Pharma advances glioblastoma trial, expands diagnostics | 1 | Investing.com | ||
| 26.02. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Corporate Update and Reports 2024 Results | 210 | GlobeNewswire (Europe) | GAITHERSBURG, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
| 26.02. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 26.02. | Shuttle Pharmaceuticals Holdings, Inc. - 10-K, Annual Report | - | SEC Filings |
Seite:
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 0,109 | +2,35 % | Innocan Pharma Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| ARZNEIWERK AG VIDA | 0,620 | +6,90 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Arzneiwerk... ► Artikel lesen | |
| CRESCO LABS | 0,611 | -3,78 % | Cresco Labs slips after delaying Q1 earnings call | ||
| CSPC PHARMA | 0,639 | -3,03 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH CIPLA USA, INC. FOR IRINOTECAN LIPOSOME INJECTION | ||
| TONIX PHARMACEUTICALS | 19,400 | -2,02 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights | FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced... ► Artikel lesen | |
| AMARIN | 8,850 | -2,75 % | Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y | ||
| NEKTAR THERAPEUTICS | 0,621 | -2,51 % | Nektar Therapeutics Q1 Loss Increases, Misses Estimates | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR) released Loss for its first quarter that increased from last year and missed the Street estimates.The company's bottom line came in at -$50.88... ► Artikel lesen | |
| JAGUAR HEALTH | 5,530 | -8,29 % | Jaguar Health, Inc.: Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates | Click here to registerCompany plans to file its Earnings Report on May 15, 2025 on Form 10-Q for the quarter ended March 31, 2025 SAN FRANCISCO, CA / ACCESS Newswire / May 14, 2025 / Jaguar Health,... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,834 | -3,47 % | XORTX Therapeutics Inc. - 20-F, Annual and transition report of foreign private issuers | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
| CANNOVUM CANNABIS | 0,226 | -14,07 % | EQS-News: Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich | EQS-News: Cannovum Cannabis AG
/ Schlagwort(e): Strategische Unternehmensentscheidung/Sonstiges
Cannovum Cannabis AG: Abwicklung bzw. Veräußerung der Beteiligungen im Cannabis-Bereich... ► Artikel lesen | |
| TALPHERA | 0,446 | -2,20 % | Talphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025... ► Artikel lesen | |
| MEDIPHARM LABS | 0,065 | +1,25 % | MediPharm Labs Corp.: MediPharm Labs Announces Strong Q1 2025 Results | Achieves Positive Adjusted EBITDA(1)
Revenue of $10.8 Million, an Increase of 11% over Q1 2024
87% Growth in International Medical Cannabis Revenue, Forming 55% of Total Revenue... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,054 | +5,88 % | BetterLife Pharma Inc.: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders | VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,008 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 10.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.02.2025ISIN NameES0105015012 LAR... ► Artikel lesen |
SHUTTLE PHARMACEUTICALS HOLDINGS INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,018 (-7,56 %) liegt der Kurs bei 0,220 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHUTTLE PHARMACEUTICALS HOLDINGS INC finden Sie auf Wallstreet Online.